Emergency Contraception in the United Kingdom

July 2013 | 29 pages | ID: EF769A80F88EN
Euromonitor International Ltd

Abstracts

In 2012, emergency contraception increased by 3% in current value terms, to reach £25 million. After the introduction of OTC emergency contraceptive pills in 2001, growth was initially rapid, as women chose the option of convenience, and purchased in a pharmacy.

Euromonitor International's Emergency Contraception in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Emergency Contraception Company Shares by Value 2008-2012
  Table 4 Emergency Contraception Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Boots UK Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 1 Boots UK Ltd: Key Facts
Summary 2 Boots UK Ltd: Operational Indicators
Company Background
Production
Summary 3 BCM: Production Statistics 2011
Competitive Positioning
Summary 4 Boots UK Ltd: Competitive Position 2012
Executive Summary
Growth Despite Challenging Times
Value-added Innovation Is Key for Consumer Health Brands
Pharmacists Are Still Key To OTC Medication
Moving on Up
Key Trends and Developments
the UK Economy Continues To Stall
Current Impact
Outlook
Future Impact
Innovate To Accumulate
the Impact of the Ageing of the UK Population on Vitamins and Dietary Supplements
the Impact of the Vat Increase and Regulatory Changes on Vitamins and Dietary Supplements, Sports Nutrition and Nrt Smoking Cessation Aids
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Penetration of Private Label by Category 2007-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
Summary 5 OTC: Switches 2010-2012
Sources
Summary 6 Research Sources